MI
REGN icon

Motiv8 Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Motiv8 Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4K Buy
+5
New +$3.4K ﹤0.01% 630

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Motiv8 Investments's REGN Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Regeneron Pharmaceuticals (REGN) in Q4 2025: 5 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #630 among its holdings.

1,388 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Motiv8 Investments held 5 shares of Regeneron Pharmaceuticals worth $4K as of Q4 2025.
  • Regeneron Pharmaceuticals was a new Motiv8 Investments position in Q4 2025.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #630 holding.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.